scispace - formally typeset
P

Peter S. DiStefano

Researcher at Millennium Pharmaceuticals

Publications -  115
Citations -  21327

Peter S. DiStefano is an academic researcher from Millennium Pharmaceuticals. The author has contributed to research in topics: Neurotrophic factors & Neurotrophin. The author has an hindex of 60, co-authored 113 publications receiving 20518 citations. Previous affiliations of Peter S. DiStefano include Regeneron & Thomas Jefferson University.

Papers
More filters
Journal ArticleDOI

Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan

TL;DR: It is shown that human Nod1 specifically detects a unique diaminopimelate-containing N-acetylglucosamine–N-acetelmuramic acid tripeptide motif found in Gram-negative bacterial peptidoglycan, resulting in activation of the transcription factor NF-κB pathway.
Journal ArticleDOI

The Receptor Tyrosine Kinase MuSK Is Required for Neuromuscular Junction Formation In Vivo

TL;DR: It is indicated that MuSK responds to a critical nerve-derived signal (agrin), and in turn activates signaling cascades responsible for all aspects of synapse formation, including organization of the postsynaptic membrane, synapse-specific transcription, and presynaptic differentiation.
Journal ArticleDOI

DNA Repair Pathway Stimulated by the Forkhead Transcription Factor FOXO3a Through the Gadd45 Protein

TL;DR: Findings indicate that in mammals FOXO3a regulates the resistance of cells to stress by inducing DNA repair and thereby may also affect organismal life-span.
Journal ArticleDOI

trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor

TL;DR: It is demonstrated that all three of these neuronal survival molecules bind similarly to the low affinity NGF receptor, but that BDNF and NT-3, unlike NGF, do not act via the high affinity N GF receptor.